63 related articles for article (PubMed ID: 1144053)
1. [Minimal cardiac transit time in thyroid disorders and in the effort syndrome].
Siebers G; Schicha H; Becker V; Vyska K; Feinendegen LE
Nucl Med (Stuttg); 1975 Mar; 14(1):22-36. PubMed ID: 1144053
[TBL] [Abstract][Full Text] [Related]
2. [Isotope-angiographic measurement of aortic flow velocity for differential diagnosis of aortic sclerosis].
Schicha H; Becker V; Vyska K; Feinendegen LE
Nucl Med (Stuttg); 1975 Mar; 14(1):12-21. PubMed ID: 1144052
[TBL] [Abstract][Full Text] [Related]
3. [Minimal cardiac transit times in the diagnosis of heart disease: measurements with the gamma retina V and indium-113m. The influence on central volume relationships of long-term digitalis therapy in patients with latent and manifest coronary insufficiency].
Freundlieb C; Vyska K; Höck A; Schicha H; Becker V; Feinendegen LE
Nucl Med (Stuttg); 1976 Feb; 15(1):9-13. PubMed ID: 768922
[TBL] [Abstract][Full Text] [Related]
4. [Minimal cardiac transit times (MTTs) in heart diagnosis--measurements with gamma-retina and indium-133m. IV. MTTs in untrained subjects and high-performance sportsmen during rest and following exertion].
Schicha H; Vyska K; Knapp W; Becker V; Heck H; Hollmann W; Feinendegen LE
Z Kardiol; 1974 Aug; 63(8):733-44. PubMed ID: 4421238
[No Abstract] [Full Text] [Related]
5. [Heart function in hyperthyroidism].
Lüderitz B
Internist (Berl); 1975 Nov; 16(11):524-9. PubMed ID: 1104512
[No Abstract] [Full Text] [Related]
6. [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function].
Biondi B; Fazio S; Palmieri EA; Tremalaterra R; Angellotti G; Bonè F; Riccio G; Cittadini A; Lombardi G; Saccà L
Cardiologia; 1999 May; 44(5):443-9. PubMed ID: 10389349
[TBL] [Abstract][Full Text] [Related]
7. [Change in myocardial hemodynamics and contractile capacity in neurocirculatory dystonia and thyrotoxicosis].
Viazitskiĭ PO; Sergeev AI
Voen Med Zh; 1975 Nov; (11):33-6. PubMed ID: 1220131
[No Abstract] [Full Text] [Related]
8. Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation.
Dufour R; Scazziga B; Schelling JL
Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):145-7. PubMed ID: 4395480
[No Abstract] [Full Text] [Related]
9. Effects of therapeutic interventions on minimal cardiac transit times and volume parameters in hypertrophic cardiomyopathy.
Lösse B; Feinendegen LE
Z Kardiol; 1987; 76 Suppl 3():46-52. PubMed ID: 3433874
[TBL] [Abstract][Full Text] [Related]
10. Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment.
Osman F; Franklyn JA; Daykin J; Chowdhary S; Holder RL; Sheppard MC; Gammage MD
Am J Cardiol; 2004 Aug; 94(4):465-9. PubMed ID: 15325930
[TBL] [Abstract][Full Text] [Related]
11. Thyroid function after surgical treatment of thyrotoxicosis. A report of 100 cases treated with propranolol before operation.
Toft AD; Irvine WJ; Sinclair I; McIntosh D; Seth J; Cameron EH
N Engl J Med; 1978 Mar; 298(12):643-7. PubMed ID: 628387
[TBL] [Abstract][Full Text] [Related]
12. Importance of T 3 (triiodothyronine) secretion in altered states of thyroid function in the rat: cold exposure, subtotal thyroidectomy, and hypophysectomy.
Nejad IF; Bollinger JA; Mitnick M; Reichlin S
Trans Assoc Am Physicians; 1972; 85():295-308. PubMed ID: 4660011
[No Abstract] [Full Text] [Related]
13. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
14. Myocardial contractility, and the effects of beta-adrenergic blockade in hypothyroidism and hyperthyroidism.
Howitt G; Rowlands DJ; Leung DY; Logan WF
Clin Sci; 1968 Jun; 34(3):485-95. PubMed ID: 5662591
[No Abstract] [Full Text] [Related]
15. Improved endothelial function and lipid profile compensate for impaired hemostatic and inflammatory status in iatrogenic chronic subclinical hyperthyroidism of thyroid cancer patients on L-t4 therapy.
Gazdag A; Nagy EV; Burman KD; Paragh G; Jenei Z
Exp Clin Endocrinol Diabetes; 2010 Jun; 118(6):381-7. PubMed ID: 19658059
[TBL] [Abstract][Full Text] [Related]
16. [Radiocardiographic functional diagnosis--determination of minimal central transit times (MTTs) using indium-113m and the gamma camera].
Feinendegen LE; Schicha H; Becker V; Vyska K; Seipel L
Verh Dtsch Ges Inn Med; 1971; 77():438-41. PubMed ID: 4949677
[No Abstract] [Full Text] [Related]
17. [Cor thyreotoxicum. Part I--new findings about its etiopathogenesis and diagnosis. Overview of problems based on 35 years' experience].
Hrnciar J
Vnitr Lek; 2002 Jan; 48(1):38-44. PubMed ID: 11852586
[TBL] [Abstract][Full Text] [Related]
18. [Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity?].
Toft P; Bøtker HE
Ugeskr Laeger; 1993 May; 155(18):1354-7. PubMed ID: 8497965
[TBL] [Abstract][Full Text] [Related]
19. Effect of thyroid state on cardiac electrical activity of the frog Rana esculenta.
Di Meo S; Piro MC; Venditti P; De Leo T
Gen Comp Endocrinol; 1995 Nov; 100(2):162-9. PubMed ID: 8582597
[TBL] [Abstract][Full Text] [Related]
20. [The cardiovascular system in functional disorders of the thyroid gland].
Dubiel JP
Przegl Lek; 1990; 47(11):770-4. PubMed ID: 2098846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
